Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovate (VATE) Amortization of Deferred Charges (2016 - 2025)

Historic Amortization of Deferred Charges for Innovate (VATE) over the last 13 years, with Q3 2025 value amounting to $5.8 million.

  • Innovate's Amortization of Deferred Charges rose 20526.32% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.8 million, marking a year-over-year increase of 15714.29%. This contributed to the annual value of $7.7 million for FY2024, which is 1159.42% up from last year.
  • Innovate's Amortization of Deferred Charges amounted to $5.8 million in Q3 2025, which was up 20526.32% from $6.3 million recorded in Q2 2025.
  • Over the past 5 years, Innovate's Amortization of Deferred Charges peaked at $7.4 million during Q1 2021, and registered a low of $200000.0 during Q4 2022.
  • Moreover, its 5-year median value for Amortization of Deferred Charges was $1.7 million (2023), whereas its average is $2.4 million.
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first plummeted by 8378.38% in 2022, then surged by 95000.0% in 2023.
  • Innovate's Amortization of Deferred Charges (Quarter) stood at $1.1 million in 2021, then crashed by 81.82% to $200000.0 in 2022, then surged by 950.0% to $2.1 million in 2023, then changed by 0.0% to $2.1 million in 2024, then soared by 176.19% to $5.8 million in 2025.
  • Its Amortization of Deferred Charges was $5.8 million in Q3 2025, compared to $6.3 million in Q2 2025 and $5.6 million in Q1 2025.